Medicare Enrolled

Dr. Veena Sengupta, M.D.

Neurology · West Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7301 MEDICAL CENTER DR, West Hills, CA 91307
8185932191
In practice since 2006 (19 years)
NPI: 1548329352 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sengupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sengupta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sengupta

Dr. Veena Sengupta is a neurology specialist in West Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sengupta performed 1,173 Medicare services across 795 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sengupta received a total of $8,367 from 43 pharmaceutical and/or device companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sengupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in CA $8,367 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,173
Medicare services
Top 29% in CA for neurology
795
Unique beneficiaries
$146
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
376 $146 $250
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
273 $87 $245
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
168 $97 $250
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
81 $404 $600
New patient office visit, complex (60-74 min) 74 $170 $385
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
70 $219 $600
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
60 $26 $100
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
30 $188 $560
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
22 $253 $650
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
19 $156 $520
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,367
Total received (2018-2024)
Avg $1,195/year across 7 years
Top 25% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
357
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,228 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,486
2023
$1,625
2022
$1,045
2021
$961
2020
$563
2019
$839
2018
$848

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$401
Teva Pharmaceuticals USA, Inc.
$381
Neurelis, Inc.
$235
Novartis Pharmaceuticals Corporation
$217
Eisai Inc.
$217
PFIZER INC.
$191
Medtronic, Inc.
$127
E.R. Squibb & Sons, L.L.C.
$124
ACADIA Pharmaceuticals Inc
$85
MDD US Operations, LLC
$73
UCB, Inc.
$61
Harmony Biosciences Llc
$49
HARMONY BIOSCIENCES LLC
$41
Amgen Inc.
$39
Biogen, Inc.
$37
JAZZ PHARMACEUTICALS INC.
$32
Amneal Pharmaceuticals LLC
$24
CSL Behring
$24
Octapharma USA, Inc.
$22
EMD Serono, Inc.
$20
Lilly USA, LLC
$20
Aucta Pharmaceuticals, Inc.
$18
BioMarin Pharmaceutical Inc.
$17
SCILEX PHARMACEUTICALS INC.
$16
Azurity Pharmaceuticals, Inc.
$15
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,645
Biohaven Pharmaceuticals, Inc.
$589
ABBVIE INC.
$455
EMD Serono, Inc.
$450
Amgen Inc.
$439
AbbVie Inc.
$414
PFIZER INC.
$410
Neurelis, Inc.
$370
Novartis Pharmaceuticals Corporation
$326
Biohaven Pharmaceutical Holding Company Ltd.
$317
Janssen Pharmaceuticals, Inc
$220
Eisai Inc.
$217
Horizon Therapeutics plc
$214
ACADIA Pharmaceuticals Inc
$208
Allergan, Inc.
$201
LivaNova USA, Inc.
$174
Harmony Biosciences LLC
$143
Medtronic, Inc.
$127
Adamas Pharmaceuticals, Inc.
$125
E.R. Squibb & Sons, L.L.C.
$124
Kyowa Kirin, Inc.
$123
Alexion Pharmaceuticals, Inc.
$122
Biogen, Inc.
$114
Allergan Inc.
$112
UCB, Inc.
$91
Mallinckrodt LLC
$90
MDD US Operations, LLC
$73
Sumitomo Pharma America, Inc.
$66
Lilly USA, LLC
$52
Harmony Biosciences Llc
$49
HARMONY BIOSCIENCES LLC
$41
Supernus Pharmaceuticals, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$32
Amneal Pharmaceuticals LLC
$24
CSL Behring
$24
Octapharma USA, Inc.
$22
Upsher-Smith Laboratories LLC
$21
GENZYME CORPORATION
$20
Aucta Pharmaceuticals, Inc.
$18
BioMarin Pharmaceutical Inc.
$17
SCILEX PHARMACEUTICALS INC.
$16
Azurity Pharmaceuticals, Inc.
$15
EISAI INC.
$14
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Apokyn · Austedo XR · BOTOX · Brineura · COMIRNATY · DUOPA · EPIDIOLEX · FABRY-DISEASE · Fycompa · GOCOVRI · HORIZANT · Hizentra · KESIMPTA · Leqembi · MAVENCLAD · Mavenclad · Motpoly XR · NAMZARIC · NOURIANZ · NUPLAZID · NURTEC ODT · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RYTARY · Rebif · Rystiggo · SOLIRIS · TROKENDI XR · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · WAKIX · ZAVZPRET · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in West Hills?
Compare neurologists in the West Hills area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
348
Per 100K population
3.5
County median income
$87,760
Nearest hospital
UCLA WEST VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sengupta is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sengupta experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Sengupta performed 376 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sengupta receive payments from pharmaceutical companies?
Yes. Dr. Sengupta received a total of $8,367 from 43 companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sengupta's costs compare to other neurologists in West Hills?
Dr. Sengupta's average Medicare payment per service is $146. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sengupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →